Adamis Pharmaceuticals Corp. (ADMP) is “One to Watch”
Adamis Pharmaceuticals Corp., an emerging biopharmaceutical company, is combining specialty pharmaceuticals and biotechnology to create treatment options in the areas of allergy, respiratory, oncology, and immunological disorders as well as for infectious diseases. With novel products and breakthrough science, the company has positioned itself to become a leader in the biopharmaceutical industry. The company's current initiatives include the development of a prefilled single-dose epinephrine syringe for which a New Drug Application (NDA) has been submitted to the FDA. Adamis is also developing inhaled therapeutics for allergic rhinitis, asthma, and COPD under a December 2010 agreement with Beximco Pharmaceuticals Ltd., a…